GeneDx (WGS) : 3-year performance

GeneDx began trading under WGS on January 10, 2023. The Company previously traded under SMFR, reflective of the company's former name, Sema4 which went public via merger with CM Life Sciences (CMLF), a special purpose acquisition company (SPAC), on July 23, 2021, at a valuation of around $3 billion.

• Sector: Healthcare
• Industry: Diagnostics & Research
• Full Time Employees: 1,000
• Founded by Eric Schadt in October 2015
• Headquartered in Stamford, Connecticut
• https://www.genedx.com/

Clinical data and genomics company 

Sema4 was spun out of Mount Sinai Health System in 2017 The Sema4 platform uses machine learning and other artificial intelligence tools to analyze a database of more than 10 million patient genomic profiles and clinical records, with the goal of improving physicians’ ability to diagnose, manage and ultimately prevent disease.